Patients with hemophilia or LQTS: strong improvement needed for both accurate registration of contraindications and in patient understanding of the risks of over-the-counter drugs

Author:

Middeldorp Anniek1,Meer Douwe van der1,Smit Jaap Jan1,de Waal Tim1,Egmond Pleun van1,Wieringa André1

Affiliation:

1. Isala Hospital

Abstract

Abstract

Purpose Certain medications are contraindicated in patients with hemophilia or Long QT Syndrome (LQTS). Accurate registration of contraindications in electronic health record (EHR) systems is essential to minimize the risks when prescribing medication by healthcare professionals. Also, the use of certain over-the-counter (OTC) medications is contraindicated in these patients. Hence, patients must be cognizant of the potential risks associated when using these medications. We aimed to quantify the accurate registration of hemophilia and LQTS within primary and secondary care and to assess the degree to which patients take into account their medical condition when visiting healthcare professionals and using over-the-counter medication. Methods Patients with hemophilia or LQTS being under treatment in Isala Hospital were included. Community pharmacists and General Practitioners (GPs) were surveyed regarding the accurate documentation of these conditions. An analysis was conducted on the prescribed medications for these patients over the past year, to determine if any were contraindicated. Additionally, patients were surveyed to assess their awareness of the medication safety risks of their medical condition. Results Of the included 32 patients with hemophilia and 21 patients with LQTS the contraindications were accurately registered by pharmacists, GPs and hospital in 86.4, 70.8 and 0% (hemophilia), and 80.0, 82.4 and 28.6% (LQTS), respectively. The majority of patients reported their disease when visiting healthcare professionals. However, of the patients with hemophilia and LQTS 20% and 40%, respectively, were unaware of the potential risks associated with OTC medication. Conclusion This study indicates that strong improvement can be achieved in accurate registration of the contraindications LQTS and hemophilia in both primary and secondary care. Enhanced registration will improve medication safety in patients when prescribed by healthcare professionals. Additionally, there is a need for increased patient education concerning medication usage, as they tend to underestimate the risks associated with (OTC) medications.

Publisher

Springer Science and Business Media LLC

Reference18 articles.

1. CONGENITAL LONG QT SYNDROME: A SYSTEMATIC REVIEW;Galić E;Acta Clin Croat,2021

2. Gastrointestinal bleeding in hemophilia as a complication of the use of over the counter non-steroidal anti-inflammatory drugs;Cagnoni PJ;Am J Hematol,1994

3. The modern treatment of haemophilia: a narrative review;Franchini M;Blood Transfus,2013

4. Hemophilia A and B: molecular and clinical similarities and differences;Castema G;Haematologica,2019

5. Orphanet (2022) Hemophilia. https://www.orpha.net/en/disease/detail/448. Accessed 3 March 2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3